An Intelligent Approach to Segment the Liver Cancer using Machine Learning Method
L. Anand, Mahesh Maurya, J. Seetha, D Nagaraju, Ananda Ravuri, R.G. Vidhya
Abstract
Cancer Liver cancer is difficult to detect and diagnose early. Machine learning has improved liver cancer diagnosis in recent years. This abstract describes a novel liver cancer detection and classification method using Autoencoder-Extreme Learning Machine (AE-ELM) and Convolutional Neural Network (CNN) technology. AE-ELM models extract features in the suggested method. The autoencoder-extreme learning machine AE-ELM technique learns high-level abstract characteristics from incoming data. AE-ELM extracts liver cancer-specific features by reducing the dimensionality of input data. A CNN model classifies the extracted features. CNNs are good at detecting spatial patterns in medical pictures like CT and MRI scans. The CNN model learns hierarchical representations of input information and classifies them into liver cancer subtypes or stages using various convolutional and pooling processes. AE-ELM and CNN are advantageous. First, AE-ELM decreases input data dimensionality to extract critical features without manual feature engineering. This simplifies feature selection and improves the model’s capacity to handle big data. Second, the CNN model uses hierarchical convolutional processes to capture subtle patterns and spatial correlations in input data, enhancing liver cancer classification accuracy. The proposed liver cancer diagnostic method works in experiments. AE-ELM and CNN models outperform classic machine learning approaches and standalone CNN models. Improved liver cancer detection accuracy, sensitivity, and specificity help healthcare practitioners make quick and precise diagnosis. Finally, AE-ELM and CNN technologies can identify and classify liver cancer. This unique strategy uses both models to extract relevant characteristics and capture complicated patterns, improving liver cancer diagnosis accuracy and efficiency. To evaluate this approach’s therapeutic promise and application in real-world healthcare settings, additional datasets are needed.